Colin Dwyer
Colin Dwyer covers breaking news for NPR. He reports on a wide array of subjects — from politics in Latin America and the Middle East, to the latest developments in sports and scientific research.
Colin began his work with NPR on the Arts Desk, where he reviewed books and produced stories on arts and culture, then went on to write a daily roundup of news in literature and the publishing industry for the Two-Way blog — named Book News, naturally.
Later, as a producer for the Digital News desk, he wrote and edited feature news coverage, curated NPR's home page and managed its social media accounts. During his time on the desk, he co-created NPR's live headline contest "Head to Head," with Camila Domonoske, and won the American Copy Editors Society's annual headline-writing prize in 2015.
These days, as a reporter for the News Desk, he writes for NPR.org, reports for the network's on-air newsmagazines, and regularly hosts NPR's daily Facebook Live segment, "Newstime." He has covered hurricanes, international elections and unfortunate marathon mishaps, among many other stories. He also had some things to say about shoes once on Invisibilia.
Colin graduated from Georgetown University with a master's degree in English literature.
-
A day after the secretary of state became the highest-ranking administration official to blame Russia for a vast hack of multiple U.S. agencies, the president suggested someone else may be to blame. -
The Food and Drug Administration greenlights the biotech firm's vaccine for emergency use in the U.S. The move bolsters a vast inoculation effort that's already underway. -
In a survey by the Kaiser Family Foundation, 71% of respondents said they would definitely or probably get inoculated — a significant leap over the 63% who said so in an August/September poll.
-
Amid a spike in new cases, leaders in Germany, the Netherlands and the Czech Republic have announced the return of strict measures to dissuade people from attending large holiday gatherings. -
Army Gen. Gustave Perna told reporters that distribution of the vaccine from Pfizer and BioNTech has begun, with shipment to 636 sites scheduled to begin on Monday. -
Pfizer and BioNTech's vaccine is the first to receive an emergency authorization from the Food and Drug Administration. Officials say it may be ready for widespread inoculations within days. -
The vaccine produced by Pfizer and BioNTech is the first to be authorized by Canadian health officials. The decision makes Canada just the third country in the world to grant such an authorization. -
At least, that's how it will look to someone craning their head aloft. On the winter solstice, the pair of gas giants will appear closer to each other in the night sky than they have in centuries. -
After years of surveys and calculations, the countries said Tuesday that the world's highest peak now stands about 29,032 feet above sea level — more than 2 feet taller than the previous consensus. -
In revised guidelines, the Centers for Disease Control and Prevention trimmed its recommended quarantine for possible exposure — from 14 days to seven or 10, depending on test results and symptoms.
